发明名称 |
ACTIVATION OF REGULATORY T CELLS BY ALPHA-MELANOCYTE STIMULATING HORMONE |
摘要 |
<p>The invention encompasses a method of down-regulating a T cell-mediated immune response, through activation or T cell receptor (TCR) stimulation of antigen-primed T cells in the presence of alpha-melanocyte stimulating hormone ( alpha -MSH), which may be optionally enhanced by adding transforming growth factor- beta 2 (TGF- beta 2) approximately 4-6 hours after the start of the primed T cells' exposure to alpha -MSH. Activation of the primed T cells may be mediated by presentation of the specific antigen to the primed T cells, or by an anti-TCR antibody or a T cell mitogen. As a result of the alpha -MSH treatment modulating the T cell activation, antigen-specific, regulatory, CD4+/CD25+ T cells are generated that produce transforming growth factor- beta (TGF- beta ) and can non-specifically down-regulate Th1-mediated inflammatory activities. The method may be used to down-regulate or suppress an autoimmune condition or a graft rejection in a transplant patient. The invention also encompasses a kit for generating regulatory T cell comprising a speciric antigen, alpha -MSH, and optionally, TGF- beta 2 and/or a T cell culture medium. Also provided are gene therapy treatments for suppressing an autoimmune or graft rejection response, or for re-establishing autotolerance, by introducing genetic material (e.g. nucleic acid) for expressing alpha -MSH or a receptor-binding portion thereof, into a localized tissue site.</p> |
申请公布号 |
WO0042856(A1) |
申请公布日期 |
2000.07.27 |
申请号 |
WO2000US01608 |
申请日期 |
2000.01.21 |
申请人 |
THE SCHEPENS EYE RESEARCH INSTITUTE, INC.;TAYLOR, ANDREW, W.;NISHIDA, TOMOMI |
发明人 |
TAYLOR, ANDREW, W.;NISHIDA, TOMOMI |
分类号 |
C12N15/09;A61K35/12;A61K35/14;A61K38/34;A61K39/00;A61K48/00;A61P29/00;A61P37/06;C12N5/0783;C12N5/10;(IPC1-7):A01N63/00 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|